Cargando…

The origin of cost–benefit analysis: a comparative view of France and the United States

BACKGROUND: Cost–benefit analysis (CBA), as a common instrument in the decision making process on how to allocate financial resources, has been widely used in various research areas and in almost all of countries over the world. However, the origin and the historical development of CBA has long been...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wei, Marggraf, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600932/
https://www.ncbi.nlm.nih.gov/pubmed/34794465
http://dx.doi.org/10.1186/s12962-021-00330-3
_version_ 1784601249617805312
author Jiang, Wei
Marggraf, Rainer
author_facet Jiang, Wei
Marggraf, Rainer
author_sort Jiang, Wei
collection PubMed
description BACKGROUND: Cost–benefit analysis (CBA), as a common instrument in the decision making process on how to allocate financial resources, has been widely used in various research areas and in almost all of countries over the world. However, the origin and the historical development of CBA has long been subject to neglect. We attempt to fill this gap and clarify the origin and the early development of CBA. METHODS: A comparative analysis is used to investigate the origin and the early development of CBA in France and the USA. The comparison is focused on two questions: (1) which criteria should be applied to decide whether or not a project should be carried out, and (2) with which procedure these criteria can be used for real projects. RESULTS: The origin of CBA can be dated back to the work of Saint-Pierre in France in 1708. Dupuit introduces the concept of consumer’s surplus that founds the economic basis of CBA. These works are not taken seriously in France and do not draw attention from other countries. Hence, until the 1930s, the principle of CBA is newly proposed in the US and the Green Book marks the mature of CBA. CONCLUSIONS: The early development of CBA in France and the US is independent from the aspects of historical background, personnel, approaches and standardization. This study could help researchers of various disciplines be sure about the history of CBA when they perform this analysis in their research areas.
format Online
Article
Text
id pubmed-8600932
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86009322021-11-19 The origin of cost–benefit analysis: a comparative view of France and the United States Jiang, Wei Marggraf, Rainer Cost Eff Resour Alloc Research BACKGROUND: Cost–benefit analysis (CBA), as a common instrument in the decision making process on how to allocate financial resources, has been widely used in various research areas and in almost all of countries over the world. However, the origin and the historical development of CBA has long been subject to neglect. We attempt to fill this gap and clarify the origin and the early development of CBA. METHODS: A comparative analysis is used to investigate the origin and the early development of CBA in France and the USA. The comparison is focused on two questions: (1) which criteria should be applied to decide whether or not a project should be carried out, and (2) with which procedure these criteria can be used for real projects. RESULTS: The origin of CBA can be dated back to the work of Saint-Pierre in France in 1708. Dupuit introduces the concept of consumer’s surplus that founds the economic basis of CBA. These works are not taken seriously in France and do not draw attention from other countries. Hence, until the 1930s, the principle of CBA is newly proposed in the US and the Green Book marks the mature of CBA. CONCLUSIONS: The early development of CBA in France and the US is independent from the aspects of historical background, personnel, approaches and standardization. This study could help researchers of various disciplines be sure about the history of CBA when they perform this analysis in their research areas. BioMed Central 2021-11-18 /pmc/articles/PMC8600932/ /pubmed/34794465 http://dx.doi.org/10.1186/s12962-021-00330-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jiang, Wei
Marggraf, Rainer
The origin of cost–benefit analysis: a comparative view of France and the United States
title The origin of cost–benefit analysis: a comparative view of France and the United States
title_full The origin of cost–benefit analysis: a comparative view of France and the United States
title_fullStr The origin of cost–benefit analysis: a comparative view of France and the United States
title_full_unstemmed The origin of cost–benefit analysis: a comparative view of France and the United States
title_short The origin of cost–benefit analysis: a comparative view of France and the United States
title_sort origin of cost–benefit analysis: a comparative view of france and the united states
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600932/
https://www.ncbi.nlm.nih.gov/pubmed/34794465
http://dx.doi.org/10.1186/s12962-021-00330-3
work_keys_str_mv AT jiangwei theoriginofcostbenefitanalysisacomparativeviewoffranceandtheunitedstates
AT marggrafrainer theoriginofcostbenefitanalysisacomparativeviewoffranceandtheunitedstates
AT jiangwei originofcostbenefitanalysisacomparativeviewoffranceandtheunitedstates
AT marggrafrainer originofcostbenefitanalysisacomparativeviewoffranceandtheunitedstates